IGF2R, insulin-like growth factor 2 receptor, is currently considered a tumor suppressor gene, but it is upregulated and correlated with poor prognosis in cervical cancer (51) and glioblastomas (52). This evidence concerns the gene IGF2R and cervical carcinoma.